These days we are hearing a lot about artificial intelligence (AI), deep learning (DL), machine learning, algorithms, robotics, etc. The hype and hysteria created over it has reached epic proportion. For the average ophthalmologist, unfamiliar with these terms, it may look little overwhelming and scary at first, since many of us find it difficult to keep pace with rapidly changing technology, scary in the sense that we may lose patients to automation and technology, even forcing the technicians to lose their jobs to the machines.
AI is human like intelligence, which the machines and computers acquire once it gets a huge volume of training data and getting better over time by taking in more data, ultimately making successful and smart judgment or predictions. [1] In ophthalmology, AI is seen to have unlimited potential to perform many tasks much better than humans, since it can process data and information much faster than humans. Various clinical applications of AI and DL are screening and diagnosis of diabetic retinopathy, age-related macular degeneration, retinopathy of prematurity, pediatric cataract, glaucoma, keratoconus, oculoplastic reconstruction, and dry eye. [2, 3] Interpretation of corneal topography, optical coherence tomography scans, visual fields and fundus photographs, looking for disease progression and predicting best treatment strategy and its success. Intraocular lens (IOL) power prediction based on adaptive learning, using pattern recognition and sophisticated data interpolation and is free of calculation bias. So, whether the third-generation theoretical formulas, ray tracing, and ultrasound biometer become obsolete like the Schiotz tonometer is anybody's guess. [4] AI has the potential right from screening to management using algorithms, making things simpler, better, and faster. [5] So that persons requiring treatment needlessly do not go blind and are managed early in the course of the disease, as well saving on vital resources and man hours.
Diabetic retinopathy has become a public health problem in India. AI and DL in ocular imaging along with telemedicine is being used to screen target population, diagnose, suggest best management protocol, and monitor for disease progression even in remote areas making it very effective tool to combat blindness. [6] AI should be seen as a tool and technique, the next big thing to happen in ophthalmology similar to the invention of ophthalmoscope, IOL, OCT, fundus camera, etc. It is for us to combine the best of our clinical skills and the tools of AI for best management practices. It should not be viewed as a magic wand for everything and pushing our own clinical skills to the background, leading to the atrophy of our skills. Since healthcare is not only science and tools, it is indeed also art and craft with effective communication skills with real intelligence in the real world. Since AI is evolving, potential technical and clinical challenges remain, medicolegal issues, understanding of algorithm results needs to be addressed. It should be "learn on the go" as we have seen only the tip of the iceberg, may be the best is yet to be discovered. Definitely AI is getting better by the day as it acquires more data and is self-evolving. [7] One concern is imperfect, yet to validated technology, causing patients harm due to misdiagnosis or incorrect prediction. Though, we cannot fault the AI alone, since it is the developer who has to teach the machine better, otherwise it may lead to patient-doctor conflict for a missed diagnosis or for implanting a wrong IOL. So the real benefit will come, when we realize how to use and develop the best of these tools for delivering care that is advanced, accurate, and humane at the same time. [8] The potential of AI can be used for teaching training purposes, student and faculty monitoring, even evaluating answer scripts in medical colleges and institutes. So teachers will have enough time to teach students human values, empathy, ethics, clinical, and communications skills, while AI will be doing the more mechanical part of the work, bringing about a paradigm change in the very functioning of the medical colleges and institutes.
In conclusion, AI and DL are necessary tools to face the challenges of the future in healthcare. One should understand the true potential and see it as an integral part of modern medical practice.
Sir, to end on a lighter note,
Examiner: What is Fincham's test, Student: Sir, my I phone has a AI tool for detecting the cause of colored halos in the eyes with 98% sensitivity and 92% specificity, Fincham's test is obsolete.
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Nil. thickness in healthy Indian population using swept-source optical coherence tomography Dear Sir, The assessment of choroidal thickness (CT) is of paramount importance in diagnosis and management of various ocular disorders. The inter-ocular asymmetry in CT should be kept in mind while analyzing the results of different studies. The authors had previously reported the normative data for sub-foveal CT (SFCT) in 119 healthy Indian patients (age 19-45 years, refractive error −6 to +4 diopters, best corrected visual acuity 20/20) using swept-source optical coherence tomography (SS-OCT, DRI-OCT, Topcon Japan).
[1] The CT was further compared between the fellow eyes in different regions of the macular area based on the ETDRS (early treatment diabetic retinopathy study) grid.
The mean CT in the right eye was significantly greater than the left eye in all EDTRS regions except the temporal inner and outer regions [see Table 1 ], with the maximum difference in the nasal outer region (mean 14.39 µm, P = 0.0001, Student t test). The individual difference in the subfoveal CT (SFCT) between the right and left eye ranged from +133 to −125 µm. The SFCT was greater in the right eye as compared to left eye in 59% of the cases (n = 70).
The inter-ocular asymmetry in CT may arise from the difference in ocular blood flow. The right ophthalmic artery receives blood from the brachiocephalic trunk which itself is more proximal to the left ventricle than the left common carotid artery which branches into the left ophthalmic artery. [2] The reason for maximum difference in the nasal macular region is not clearly understood. We hypothesize dominance of 1 eye in an individual to have some contribution to the asymmetry but this could not be confirmed retrospectively as this was a cross sectional study.
Similar inter-ocular differences in CT have been previously reported in Caucasian and Middle-Eastern patients using enhanced depth spectral domain OCT (SD-OCT). [3] [4] [5] As SS-OCT provides a better delineation of the CSI than SD-OCT, it may be superior in evaluating the CT. Ruiz-Medrano et al. had used SS-OCT for studying the inter-ocular CT difference in Spanish population.
[2] The present study is the first to report the inter-ocular asymmetry in CT on SS-OCT in the Indian population.
Nil. (CT-choroidal thickness, R-right eye, L-left eye, D-difference between right and left (R-L), CSF-central subfoveal, NIM-nasal inner macula, NOM-nasal outer macula, TIM-temporal inner macula, TOM-temporal outer macula, SIM-superior inner macula, SOM-superior outer macula, IIM-inferior inner macula, IOM-inferior outer macula)
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